Muscle Anabolic Response to β2-adrenergic Stimulation With Increased Amino Acid Availability.

Launched by UNIVERSITY OF COPENHAGEN · Oct 22, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how the availability of amino acids, which are the building blocks of proteins, affects the way muscles respond to a specific type of stimulation called beta2-adrenergic stimulation. This research is being conducted with young, healthy men and women who are physically active. The goal is to understand how these factors work together to support muscle growth and development.

To participate in this study, individuals must be between 18 and 40 years old and engage in physical activities for at least 5 hours each week. They should also have a high level of fitness, which is measured by their maximum oxygen uptake. However, people who smoke, have certain health conditions, are pregnant, or have donated blood in the last three months cannot participate. If you join, you can expect to undergo tests that will help researchers learn more about muscle response and growth. This research could provide valuable insights into nutrition and exercise for maintaining healthy muscles.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age 18-40
• • Physically active \>5 hours a week
• • Maximum oxygen uptake classified as high or very high
• Exclusion Criteria:
• • Active smoker currently or within the past 5 years
• • Regular intake of medication deemed by the responsible study physician to affect the test parameters (hormonal contraception is accepted for women)
• • Chronic or acute illness deemed by the responsible study physician to affect the test parameters
• • Deviation from the study protocol
• • Lean mass index \>21 kg/m²
• • Pregnancy
• • Smoker
• • Blood donation during the past 3 months